Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Central Nervous System Neoplasms 3Fatigue 2Breast Neoplasms 2Brain Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Radiation Injuries 1Ototoxicity 1Melanoma 1Gliosarcoma 1Glioblastoma 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1

Interventions

Fluorouracil 70Leucovorin 66Oxaliplatin 50Irinotecan 32Cetuximab 23Bevacizumab 20Capecitabine 16Chemotherapy, Adjuvant 15Folfox protocol 13sargramostim 7Neoadjuvant Therapy 7Erlotinib Hydrochloride 7aldesleukin 5Trastuzumab 5Melphalan 5Magnetic Resonance Spectroscopy 5Gene Expression Profiling 5Floxuridine 5Biopsy 52,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5dehydroftorafur 4Specimen Handling 4Polymerase Chain Reaction 4Interferon-alpha 4Immunoglobulin G 4Gemcitabine 4Gefitinib 4Disulfides 4Cyclophosphamide 4fludarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Colonic Neoplasms × Mental Status and Dementia Tests × Clear all
NCT00975897 2013-12-19

Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer

National Cancer Institute (NCI)

Phase 2/3 Completed
3,240 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡